Clinical Trials Logo

Clinical Trial Summary

Intraabdominal fungal infections with Candida are constantly increasing. Their diagnosis and treatment is difficult. Morbidity and mortality are high. Β-D-Glucan has been proposed as a marker of systemic fungal infection in candidemia. Moreover, its kinetics is associated with therapeutic success. On the other hand, there are no data on intraabdominal infections that are much more frequent. The objective of the study is to evaluate the initial levels of β-D-glucan and its daily kinetics during the treatment of fungal peritonitis in resuscitation compared to a control group with a yeast-free peritonitis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03140748
Study type Interventional
Source Centre Hospitalier Universitaire, Amiens
Contact
Status Completed
Phase N/A
Start date May 1, 2018
Completion date June 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT03641131 - Ampholipad Real-World Data in Taiwan
Completed NCT03203551 - Clinical and Laboratorial Evaluation of the Desinfection Solutions in Candida Species From Total Prostheses and Palate of Total Edentulous. N/A
Not yet recruiting NCT03666195 - The Anti-microbial Effect of Titanium Dioxide Nano Particles in Complete Dentures Made for Edentulous Patients N/A
Active, not recruiting NCT06146504 - Clinical Study to Evaluate the Efficacy of an Anti-Fungal Supplement N/A
Completed NCT01495039 - Antifungal Prophylaxis in Intensive Care Unit (ICU) Patients Phase 4
Completed NCT04935463 - Mucormycosis in COVID-19
Completed NCT05720728 - Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized Patients
Completed NCT01743690 - The Use of Probiotics in Patients With Symptomatic Oral Lichen Planus N/A
Completed NCT03630770 - Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida Phase 1
Recruiting NCT05908682 - Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
Not yet recruiting NCT05761197 - Oropharyngeal Candidiasis (OPC) and S-ECC
Recruiting NCT05225493 - HIV Indicator Diseases in Hospital and Primary Care
Completed NCT04148287 - An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris Phase 2